IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 238 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $112,740 | -15.6% | 24,778 | +30.5% | 0.00% | – |
| Q2 2023 | $133,633 | -3.9% | 18,982 | -16.6% | 0.00% | – |
| Q1 2023 | $139,033 | -40.3% | 22,755 | +62.3% | 0.00% | – |
| Q1 2022 | $233,000 | +2.2% | 14,017 | +17.6% | 0.00% | – |
| Q4 2021 | $228,000 | -21.9% | 11,918 | +0.5% | 0.00% | – |
| Q3 2021 | $292,000 | -12.0% | 11,854 | -7.0% | 0.00% | – |
| Q2 2021 | $332,000 | -21.7% | 12,744 | -4.9% | 0.00% | – |
| Q1 2021 | $424,000 | -31.7% | 13,400 | +0.1% | 0.00% | – |
| Q4 2020 | $621,000 | +29.1% | 13,392 | -8.3% | 0.00% | – |
| Q3 2020 | $481,000 | +34.4% | 14,612 | +12.2% | 0.00% | – |
| Q2 2020 | $358,000 | +6.5% | 13,025 | +16.2% | 0.00% | – |
| Q1 2020 | $336,000 | – | 11,208 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |